BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 21 newly-hired employees stock options to purchase an agg...

Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler? — Oct 11th, 2024

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ranks among the list of stocks with improving technical rating according to Piper Sandler. The start of October has see...

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 21 newly-hired employees stock options to purchase an agg...

Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler? — Oct 11th, 2024

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ranks among the list of stocks with improving technical rating according to Piper Sandler. The start of October has see...

BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2 — Oct 9th, 2024

We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growt...

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 21 newly-hired employees stock options to purchase an agg...

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 21 newly-hired employees stock options to purchase an agg...

BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2 — Oct 9th, 2024

We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growt...

Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler? — Oct 11th, 2024

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ranks among the list of stocks with improving technical rating according to Piper Sandler. The start of October has see...

BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2 — Oct 9th, 2024

We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growt...

BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2 — Oct 9th, 2024

We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growt...

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 21 newly-hired employees stock options to purchase an agg...

BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2 — Oct 9th, 2024

We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growt...

Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler? — Oct 11th, 2024

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ranks among the list of stocks with improving technical rating according to Piper Sandler. The start of October has see...

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 21 newly-hired employees stock options to purchase an agg...

With 80% institutional ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a favorite amongst the big guns — Sep 30th, 2024

Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to their trading actions The top 12 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future perfo...

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 21 newly-hired employees stock options to purchase an agg...

With 80% institutional ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a favorite amongst the big guns — Sep 30th, 2024

Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to their trading actions The top 12 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future perfo...

BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2 — Oct 9th, 2024

We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growt...

Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler? — Oct 11th, 2024

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ranks among the list of stocks with improving technical rating according to Piper Sandler. The start of October has see...

With 80% institutional ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a favorite amongst the big guns — Sep 30th, 2024

Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to their trading actions The top 12 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future perfo...

Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler? — Oct 11th, 2024

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ranks among the list of stocks with improving technical rating according to Piper Sandler. The start of October has see...

Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler? — Oct 11th, 2024

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ranks among the list of stocks with improving technical rating according to Piper Sandler. The start of October has see...

Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler? — Oct 11th, 2024

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ranks among the list of stocks with improving technical rating according to Piper Sandler. The start of October has see...

BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2 — Oct 9th, 2024

We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growt...

With 80% institutional ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a favorite amongst the big guns — Sep 30th, 2024

Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to their trading actions The top 12 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future perfo...

BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2 — Oct 9th, 2024

We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growt...

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 21 newly-hired employees stock options to purchase an agg...

With 80% institutional ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a favorite amongst the big guns — Sep 30th, 2024

Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to their trading actions The top 12 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future perfo...

With 80% institutional ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a favorite amongst the big guns — Sep 30th, 2024

Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to their trading actions The top 12 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future perfo...

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 21 newly-hired employees stock options to purchase an agg...

With 80% institutional ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a favorite amongst the big guns — Sep 30th, 2024

Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to their trading actions The top 12 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future perfo...